ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immune System Booster Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-3H17441
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Immune System Booster Market Research Report 2024
BUY CHAPTERS

Global Immune System Booster Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-3H17441
Report
November 2025
Pages:157
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fonterra Co-operative
Nestlé
Olam
Conagra Brands
Biotec Pharmacon
AngelYeast
Lallemand
Cipla Ltd
Takara Bio
Mitushi Biopharma
Meteoric Biopharmaceuticals
Oriental Yeast

Immune System Booster Market

The global Immune System Booster market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Adults accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Immune System Booster leading manufacturers including Danone, Fonterra Co-Operative, Nestlé, Olam, Conagra Brands, Biotec Pharmacon, AngelYeast, Lallemand, Cipla, Takara Bio, etc., dominate supply; the top five capture approximately % of global revenue, with Danone leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Immune System Booster market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Immune System Booster Market Report

Report Metric Details
Report Name Immune System Booster Market
Segment by Type
  • Tablet
  • Capsule
  • Powder
  • Other
Segment by Application
  • Adults
  • Children
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Danone, Fonterra Co-Operative, Nestlé, Olam, Conagra Brands, Biotec Pharmacon, AngelYeast, Lallemand, Cipla, Takara Bio, Mitushi Biopharma, Meteoric Biopharmaceuticals, Oriental Yeast
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Immune System Booster study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Immune System Booster Market report?

Ans: The main players in the Immune System Booster Market are Danone, Fonterra Co-Operative, Nestlé, Olam, Conagra Brands, Biotec Pharmacon, AngelYeast, Lallemand, Cipla, Takara Bio, Mitushi Biopharma, Meteoric Biopharmaceuticals, Oriental Yeast

What are the Application segmentation covered in the Immune System Booster Market report?

Ans: The Applications covered in the Immune System Booster Market report are Adults, Children

What are the Type segmentation covered in the Immune System Booster Market report?

Ans: The Types covered in the Immune System Booster Market report are Tablet, Capsule, Powder, Other

1 Study Coverage
1.1 Introduction to Immune System Booster: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Immune System Booster Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Powder
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Immune System Booster Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Immune System Booster Revenue Estimates and Forecasts 2020-2031
2.2 Global Immune System Booster Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Immune System Booster Sales Estimates and Forecasts 2020-2031
2.4 Global Immune System Booster Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Immune System Booster Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Immune System Booster Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Tablet Market Size by Manufacturers
3.5.2 Capsule Market Size by Manufacturers
3.5.3 Powder Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Immune System Booster Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Immune System Booster Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Immune System Booster Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Immune System Booster Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Immune System Booster Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Immune System Booster Sales and Revenue by Type (2020-2031)
6.4 North America Immune System Booster Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Immune System Booster Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Immune System Booster Sales and Revenue by Type (2020-2031)
7.4 Europe Immune System Booster Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Immune System Booster Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Immune System Booster Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Immune System Booster Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Immune System Booster Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Immune System Booster Sales and Revenue by Type (2020-2031)
9.4 Central and South America Immune System Booster Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Immune System Booster Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Immune System Booster Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Immune System Booster Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Immune System Booster Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Danone
11.1.1 Danone Corporation Information
11.1.2 Danone Business Overview
11.1.3 Danone Immune System Booster Product Models, Descriptions and Specifications
11.1.4 Danone Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Danone Immune System Booster Sales by Product in 2024
11.1.6 Danone Immune System Booster Sales by Application in 2024
11.1.7 Danone Immune System Booster Sales by Geographic Area in 2024
11.1.8 Danone Immune System Booster SWOT Analysis
11.1.9 Danone Recent Developments
11.2 Fonterra Co-Operative
11.2.1 Fonterra Co-Operative Corporation Information
11.2.2 Fonterra Co-Operative Business Overview
11.2.3 Fonterra Co-Operative Immune System Booster Product Models, Descriptions and Specifications
11.2.4 Fonterra Co-Operative Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Fonterra Co-Operative Immune System Booster Sales by Product in 2024
11.2.6 Fonterra Co-Operative Immune System Booster Sales by Application in 2024
11.2.7 Fonterra Co-Operative Immune System Booster Sales by Geographic Area in 2024
11.2.8 Fonterra Co-Operative Immune System Booster SWOT Analysis
11.2.9 Fonterra Co-Operative Recent Developments
11.3 Nestlé
11.3.1 Nestlé Corporation Information
11.3.2 Nestlé Business Overview
11.3.3 Nestlé Immune System Booster Product Models, Descriptions and Specifications
11.3.4 Nestlé Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Nestlé Immune System Booster Sales by Product in 2024
11.3.6 Nestlé Immune System Booster Sales by Application in 2024
11.3.7 Nestlé Immune System Booster Sales by Geographic Area in 2024
11.3.8 Nestlé Immune System Booster SWOT Analysis
11.3.9 Nestlé Recent Developments
11.4 Olam
11.4.1 Olam Corporation Information
11.4.2 Olam Business Overview
11.4.3 Olam Immune System Booster Product Models, Descriptions and Specifications
11.4.4 Olam Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Olam Immune System Booster Sales by Product in 2024
11.4.6 Olam Immune System Booster Sales by Application in 2024
11.4.7 Olam Immune System Booster Sales by Geographic Area in 2024
11.4.8 Olam Immune System Booster SWOT Analysis
11.4.9 Olam Recent Developments
11.5 Conagra Brands
11.5.1 Conagra Brands Corporation Information
11.5.2 Conagra Brands Business Overview
11.5.3 Conagra Brands Immune System Booster Product Models, Descriptions and Specifications
11.5.4 Conagra Brands Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Conagra Brands Immune System Booster Sales by Product in 2024
11.5.6 Conagra Brands Immune System Booster Sales by Application in 2024
11.5.7 Conagra Brands Immune System Booster Sales by Geographic Area in 2024
11.5.8 Conagra Brands Immune System Booster SWOT Analysis
11.5.9 Conagra Brands Recent Developments
11.6 Biotec Pharmacon
11.6.1 Biotec Pharmacon Corporation Information
11.6.2 Biotec Pharmacon Business Overview
11.6.3 Biotec Pharmacon Immune System Booster Product Models, Descriptions and Specifications
11.6.4 Biotec Pharmacon Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Biotec Pharmacon Recent Developments
11.7 AngelYeast
11.7.1 AngelYeast Corporation Information
11.7.2 AngelYeast Business Overview
11.7.3 AngelYeast Immune System Booster Product Models, Descriptions and Specifications
11.7.4 AngelYeast Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 AngelYeast Recent Developments
11.8 Lallemand
11.8.1 Lallemand Corporation Information
11.8.2 Lallemand Business Overview
11.8.3 Lallemand Immune System Booster Product Models, Descriptions and Specifications
11.8.4 Lallemand Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Lallemand Recent Developments
11.9 Cipla
11.9.1 Cipla Corporation Information
11.9.2 Cipla Business Overview
11.9.3 Cipla Immune System Booster Product Models, Descriptions and Specifications
11.9.4 Cipla Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Cipla Recent Developments
11.10 Takara Bio
11.10.1 Takara Bio Corporation Information
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Immune System Booster Product Models, Descriptions and Specifications
11.10.4 Takara Bio Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Takara Bio Recent Developments
11.11 Mitushi Biopharma
11.11.1 Mitushi Biopharma Corporation Information
11.11.2 Mitushi Biopharma Business Overview
11.11.3 Mitushi Biopharma Immune System Booster Product Models, Descriptions and Specifications
11.11.4 Mitushi Biopharma Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Mitushi Biopharma Recent Developments
11.12 Meteoric Biopharmaceuticals
11.12.1 Meteoric Biopharmaceuticals Corporation Information
11.12.2 Meteoric Biopharmaceuticals Business Overview
11.12.3 Meteoric Biopharmaceuticals Immune System Booster Product Models, Descriptions and Specifications
11.12.4 Meteoric Biopharmaceuticals Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Meteoric Biopharmaceuticals Recent Developments
11.13 Oriental Yeast
11.13.1 Oriental Yeast Corporation Information
11.13.2 Oriental Yeast Business Overview
11.13.3 Oriental Yeast Immune System Booster Product Models, Descriptions and Specifications
11.13.4 Oriental Yeast Immune System Booster Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Oriental Yeast Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Immune System Booster Industry Chain
12.2 Immune System Booster Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Immune System Booster Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Immune System Booster Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Immune System Booster Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Immune System Booster Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Fonterra Co-operative
Nestlé
Olam
Conagra Brands
Biotec Pharmacon
AngelYeast
Lallemand
Cipla Ltd
Takara Bio
Mitushi Biopharma
Meteoric Biopharmaceuticals
Oriental Yeast
List of Tables
 Table 1. Global Immune System Booster Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Immune System Booster Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Immune System Booster Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Immune System Booster Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Immune System Booster Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Immune System Booster Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Immune System Booster Sales by Region (2020-2025) & (K Units)
 Table 8. Global Immune System Booster Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Immune System Booster Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Immune System Booster Sales Share by Manufacturers (2020-2025)
 Table 12. Global Immune System Booster Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Immune System Booster Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Immune System Booster by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune System Booster as of 2024)
 Table 16. Global Immune System Booster Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Immune System Booster Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Immune System Booster Manufacturing Base and Headquarters
 Table 19. Global Immune System Booster Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Immune System Booster Sales by Type (2020-2025) & (K Units)
 Table 23. Global Immune System Booster Sales by Type (2026-2031) & (K Units)
 Table 24. Global Immune System Booster Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Immune System Booster Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Immune System Booster ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Immune System Booster Sales by Application (2020-2025) & (K Units)
 Table 29. Global Immune System Booster Sales by Application (2026-2031) & (K Units)
 Table 30. Immune System Booster High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Immune System Booster Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Immune System Booster Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Immune System Booster ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Immune System Booster Growth Accelerators and Market Barriers
 Table 37. North America Immune System Booster Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Immune System Booster Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Immune System Booster Growth Accelerators and Market Barriers
 Table 40. Europe Immune System Booster Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Immune System Booster Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Immune System Booster Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Immune System Booster Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Immune System Booster Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Immune System Booster Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Immune System Booster Investment Opportunities and Key Challenges
 Table 47. Central and South America Immune System Booster Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Immune System Booster Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Immune System Booster Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Danone Corporation Information
 Table 51. Danone Description and Major Businesses
 Table 52. Danone Product Models, Descriptions and Specifications
 Table 53. Danone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Danone Sales Value Proportion by Product in 2024
 Table 55. Danone Sales Value Proportion by Application in 2024
 Table 56. Danone Sales Value Proportion by Geographic Area in 2024
 Table 57. Danone Immune System Booster SWOT Analysis
 Table 58. Danone Recent Developments
 Table 59. Fonterra Co-Operative Corporation Information
 Table 60. Fonterra Co-Operative Description and Major Businesses
 Table 61. Fonterra Co-Operative Product Models, Descriptions and Specifications
 Table 62. Fonterra Co-Operative Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Fonterra Co-Operative Sales Value Proportion by Product in 2024
 Table 64. Fonterra Co-Operative Sales Value Proportion by Application in 2024
 Table 65. Fonterra Co-Operative Sales Value Proportion by Geographic Area in 2024
 Table 66. Fonterra Co-Operative Immune System Booster SWOT Analysis
 Table 67. Fonterra Co-Operative Recent Developments
 Table 68. Nestlé Corporation Information
 Table 69. Nestlé Description and Major Businesses
 Table 70. Nestlé Product Models, Descriptions and Specifications
 Table 71. Nestlé Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Nestlé Sales Value Proportion by Product in 2024
 Table 73. Nestlé Sales Value Proportion by Application in 2024
 Table 74. Nestlé Sales Value Proportion by Geographic Area in 2024
 Table 75. Nestlé Immune System Booster SWOT Analysis
 Table 76. Nestlé Recent Developments
 Table 77. Olam Corporation Information
 Table 78. Olam Description and Major Businesses
 Table 79. Olam Product Models, Descriptions and Specifications
 Table 80. Olam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Olam Sales Value Proportion by Product in 2024
 Table 82. Olam Sales Value Proportion by Application in 2024
 Table 83. Olam Sales Value Proportion by Geographic Area in 2024
 Table 84. Olam Immune System Booster SWOT Analysis
 Table 85. Olam Recent Developments
 Table 86. Conagra Brands Corporation Information
 Table 87. Conagra Brands Description and Major Businesses
 Table 88. Conagra Brands Product Models, Descriptions and Specifications
 Table 89. Conagra Brands Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Conagra Brands Sales Value Proportion by Product in 2024
 Table 91. Conagra Brands Sales Value Proportion by Application in 2024
 Table 92. Conagra Brands Sales Value Proportion by Geographic Area in 2024
 Table 93. Conagra Brands Immune System Booster SWOT Analysis
 Table 94. Conagra Brands Recent Developments
 Table 95. Biotec Pharmacon Corporation Information
 Table 96. Biotec Pharmacon Description and Major Businesses
 Table 97. Biotec Pharmacon Product Models, Descriptions and Specifications
 Table 98. Biotec Pharmacon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Biotec Pharmacon Recent Developments
 Table 100. AngelYeast Corporation Information
 Table 101. AngelYeast Description and Major Businesses
 Table 102. AngelYeast Product Models, Descriptions and Specifications
 Table 103. AngelYeast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. AngelYeast Recent Developments
 Table 105. Lallemand Corporation Information
 Table 106. Lallemand Description and Major Businesses
 Table 107. Lallemand Product Models, Descriptions and Specifications
 Table 108. Lallemand Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Lallemand Recent Developments
 Table 110. Cipla Corporation Information
 Table 111. Cipla Description and Major Businesses
 Table 112. Cipla Product Models, Descriptions and Specifications
 Table 113. Cipla Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Cipla Recent Developments
 Table 115. Takara Bio Corporation Information
 Table 116. Takara Bio Description and Major Businesses
 Table 117. Takara Bio Product Models, Descriptions and Specifications
 Table 118. Takara Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Takara Bio Recent Developments
 Table 120. Mitushi Biopharma Corporation Information
 Table 121. Mitushi Biopharma Description and Major Businesses
 Table 122. Mitushi Biopharma Product Models, Descriptions and Specifications
 Table 123. Mitushi Biopharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Mitushi Biopharma Recent Developments
 Table 125. Meteoric Biopharmaceuticals Corporation Information
 Table 126. Meteoric Biopharmaceuticals Description and Major Businesses
 Table 127. Meteoric Biopharmaceuticals Product Models, Descriptions and Specifications
 Table 128. Meteoric Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Meteoric Biopharmaceuticals Recent Developments
 Table 130. Oriental Yeast Corporation Information
 Table 131. Oriental Yeast Description and Major Businesses
 Table 132. Oriental Yeast Product Models, Descriptions and Specifications
 Table 133. Oriental Yeast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Oriental Yeast Recent Developments
 Table 135. Key Raw Materials Distribution
 Table 136. Raw Materials Key Suppliers
 Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 138. Milestones in Production Technology Evolution
 Table 139. Distributors List
 Table 140. Market Trends and Market Evolution
 Table 141. Market Drivers and Opportunities
 Table 142. Market Challenges, Risks, and Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources


List of Figures
 Figure 1. Immune System Booster Product Picture
 Figure 2. Global Immune System Booster Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Tablet Product Picture
 Figure 4. Capsule Product Picture
 Figure 5. Powder Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Immune System Booster Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Adults
 Figure 9. Children
 Figure 10. Immune System Booster Report Years Considered
 Figure 11. Global Immune System Booster Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Immune System Booster Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Immune System Booster Revenue Market Share by Region (2020-2031)
 Figure 15. Global Immune System Booster Sales (2020-2031) & (K Units)
 Figure 16. Global Immune System Booster Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Immune System Booster Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Immune System Booster Sales Volume Market Share in 2024
 Figure 19. Global Immune System Booster Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Tablet Revenue Market Share by Manufacturer in 2024
 Figure 22. Capsule Revenue Market Share by Manufacturer in 2024
 Figure 23. Powder Revenue Market Share by Manufacturer in 2024
 Figure 24. Other Revenue Market Share by Manufacturer in 2024
 Figure 25. Global Immune System Booster Sales Market Share by Type (2020-2031)
 Figure 26. Global Immune System Booster Revenue Market Share by Type (2020-2031)
 Figure 27. Global Immune System Booster Sales Market Share by Application (2020-2031)
 Figure 28. Global Immune System Booster Revenue Market Share by Application (2020-2031)
 Figure 29. North America Immune System Booster Sales YoY (2020-2031) & (K Units)
 Figure 30. North America Immune System Booster Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. North America Top 5 Manufacturers Immune System Booster Sales Revenue (US$ Million) in 2024
 Figure 32. North America Immune System Booster Sales Volume (K Units) by Type (2020- 2031)
 Figure 33. North America Immune System Booster Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 34. North America Immune System Booster Sales Volume (K Units) by Application (2020-2031)
 Figure 35. North America Immune System Booster Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 36. US Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 37. Canada Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 38. Mexico Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 39. Europe Immune System Booster Sales YoY (2020-2031) & (K Units)
 Figure 40. Europe Immune System Booster Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Europe Top 5 Manufacturers Immune System Booster Sales Revenue (US$ Million) in 2024
 Figure 42. Europe Immune System Booster Sales Volume (K Units) by Type (2020-2031)
 Figure 43. Europe Immune System Booster Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Europe Immune System Booster Sales Volume (K Units) by Application (2020-2031)
 Figure 45. Europe Immune System Booster Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Germany Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 47. France Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 48. U.K. Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 49. Italy Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 50. Russia Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Immune System Booster Sales YoY (2020-2031) & (K Units)
 Figure 52. Asia-Pacific Immune System Booster Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Top 8 Manufacturers Immune System Booster Sales Revenue (US$ Million) in 2024
 Figure 54. Asia-Pacific Immune System Booster Sales Volume (K Units) by Type (2020- 2031)
 Figure 55. Asia-Pacific Immune System Booster Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 56. Asia-Pacific Immune System Booster Sales Volume (K Units) by Application (2020-2031)
 Figure 57. Asia-Pacific Immune System Booster Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Indonesia Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 59. Japan Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 60. South Korea Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 61. China Taiwan Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 62. India Immune System Booster Revenue (2020-2031) & (US$ Million)
 Figure 63. Central and South America Immune System Booster Sales YoY (2020-2031) & (K Units)
 Figure 64. Central and South America Immune System Booster Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Central and South America Top 5 Manufacturers Immune System Booster Sales Revenue (US$ Million) in 2024
 Figure 66. Central and South America Immune System Booster Sales Volume (K Units) by Type (2021-2031)
 Figure 67. Central and South America Immune System Booster Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 68. Central and South America Immune System Booster Sales Volume (K Units) by Application (2020-2031)
 Figure 69. Central and South America Immune System Booster Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Brazil Immune System Booster Revenue (2020-2025) & (US$ Million)
 Figure 71. Argentina Immune System Booster Revenue (2020-2025) & (US$ Million)
 Figure 72. Middle East, and Africa Immune System Booster Sales YoY (2020-2031) & (K Units)
 Figure 73. Middle East and Africa Immune System Booster Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Middle East and Africa Top 5 Manufacturers Immune System Booster Sales Revenue (US$ Million) in 2024
 Figure 75. Middle East and Africa Immune System Booster Sales Volume (K Units) by Type (2021-2031)
 Figure 76. South America Immune System Booster Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Middle East and Africa Immune System Booster Sales Volume (K Units) by Application (2020-2031)
 Figure 78. Middle East and Africa Immune System Booster Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. GCC Countries Immune System Booster Revenue (2020-2025) & (US$ Million)
 Figure 80. Turkey Immune System Booster Revenue (2020-2025) & (US$ Million)
 Figure 81. Egypt Immune System Booster Revenue (2020-2025) & (US$ Million)
 Figure 82. South Africa Immune System Booster Revenue (2020-2025) & (US$ Million)
 Figure 83. Immune System Booster Industry Chain Mapping
 Figure 84. Regional Immune System Booster Manufacturing Base Distribution (%)
 Figure 85. Global Immune System Booster Production Market Share by Region (2020-2031)
 Figure 86. Immune System Booster Production Process
 Figure 87. Regional Immune System Booster Production Cost Structure
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Immune Boosting Health Products Market Research Report 2024
Global Adult Immune Boosting Supplements Market Research Report 2024
Immune Boosting Dietary Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immunity Boosting Drinks Market Research Report 2025
Global Immunity Boosting Food Market Research Report 2024
Global Pressure Booster Market Research Report 2024
Global Vacuum Boosters Market Research Report 2025
Global Immune Boosting Candy Market Research Report 2024
Global Air Boosters Market Research Report 2025
Global Immune Adjuvant Market Research Report 2024
Global Immune Support Supplements Market Research Report 2025
Global Hydration Boosters Market Research Report 2024
Global Solid Booster Market Research Report 2025
Global Nitrogen Booster Market Research Report 2025
Global Air Pressure Booster System Market Research Report 2024
Global Oxygen Booster Market Research Report 2025
Global UV Booster Market Research Report 2025
Global Health Product for Immune Market Research Report 2024
Global Human Immune Health Supplements Market Research Report 2024
Global Nitrogen Gas Booster Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions